Published in Arch Dermatol Forsch on January 01, 1971
Autoradiographic in vitro-examination of psoriatic skin before, during and after dithranol treatment. Arch Dermatol Forsch (1973) 1.27
[The effect of salicylic acid on epidermal cell proliferation kinetics in psoriasis. Autoradiographic in vitro-investigations(author's transl)]. Arch Dermatol Forsch (1975) 0.98
[Histopathology and histochemistry of psoriasis under photochemotherapy (author's transl)]. Arch Dermatol Res (1977) 0.92
[Inhibitory action of glucocorticoids on glucose-6-phosphate dehydrogenase activty. A screening of antipsoriatic effects (author's transl)]. Arch Dermatol Forsch (1974) 0.86
[Enzyme-histochemical structure of the epidermis in atopic dermatitis as compared to psoriasis vulgaris (author's transl)]. Arch Dermatol Forsch (1973) 0.85
[Inhibition of enzyme activities in vitro by dithranol (Cignolin)]. Arch Dermatol Forsch (1972) 0.82
[Skin impedance and phoreographic index in psoriasis. Relationship with action kinetics of three treatments]. Arch Dermatol Res (1979) 0.76
Professor Dr. Dr. h. c. Otto Braun-Falco. Arch Dermatol Res (1987) 0.75
The histochemistry of psoriasis. Ann N Y Acad Sci (1958) 2.96
[On the morphogenesis of psoriatic skin reactions. Amorphologico-histochemical study]. Arch Klin Exp Dermatol (1963) 2.67
[ON THE INFLUENCE OF LOCAL OCCLUSIVE THERAPY WITH FLUORANDRENOLONE ON PSORIATIC SKIN REACTION. HISTOLOGICAL AND HISTOCHEMICAL STUDY]. Arch Klin Exp Dermatol (1963) 2.43
[The existence of the parakeratotic form of cornification from the histochemical point of view]. Klin Wochenschr (1957) 2.25
[Activity pattern of enzymes of the energy producing metabolism in the normal human epidermis and in psoriasis vulgaris. II]. Arch Klin Exp Dermatol (1966) 1.95
The primary histologic lesion of seborrheic dermatitis and psoriasis. J Invest Dermatol (1966) 1.74
[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60
[Histological and histochemical changes in psoriatic foci during enteral triamcinolone treatment]. Acta Histochem (1959) 1.52
[Inhibitory effect of local antipsoriatic agents on respiration of human and animal skin]. Arch Klin Exp Dermatol (1969) 1.38
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
[Experimental studies of the mechanism of action of chrysarobin and dithranol in psoriasis (evidence for a cytostatic effect on the epidermis)]. Dermatologica (1965) 1.31
[Leukotactic properties of psoriasis scales]. Hautarzt (1966) 1.27
[Growth dynamics of epidermis and papillary bodies after local applications of vitamin A acid. Biometrical studies of the guinea pig ear]. Arch Klin Exp Dermatol (1968) 1.24
Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22
[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19
[The effect of external antipsoriatic drugs on the cell respiration]. Arch Klin Exp Dermatol (1966) 1.16
[On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.15
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11
[Biochemical studies on the chemotherapy of psoriasis]. Arch Klin Exp Dermatol (1970) 1.10
The inhibitory effect of dithranol (anthralin) on DNA synthesis. Acta Derm Venereol (1966) 1.07
[The vascular reaction in psoriasis vulgaris (histological and capillary microscopic studies). 3. The experimental Koebner phenomenon]. Arch Klin Exp Dermatol (1966) 1.05
[On the problem of optimal reaction conditions in the histochemical demonstration of enzymes of energy-producing metabolism in the epidermis. II. Aldolase, tetrazolium reductase, cytochrome oxidase, ubiquinone]. Arch Klin Exp Dermatol (1966) 1.00
[Enzyme-chemical aspects of antipsoriatic therapy]. Arch Klin Exp Dermatol (1966) 0.99
[Studies on the enzyme inhibiting effect of 1,8-dihydroxy-anthranol-9 (Cignolin)]. Dermatologica (1968) 0.98
[Topical treatment of normal and pathological human skin with vitamin A acid (tretinoin)]. Arch Klin Exp Dermatol (1971) 0.96
[On the mechanism of action of 1,8-dihydroxy-9-anthrone (anthraline). I. Effect of 1,8-dihydroxy-9-anthrone on the metabolism of RNA in rat liver nuclei in vitro]. Hoppe Seylers Z Physiol Chem (1969) 0.96
Dermal glycosaminoglycans in psoriasis. J Invest Dermatol (1970) 0.93
[Mast cells in skin altered by psoriasis--before, during and after cignolin therapy]. Dermatol Wochenschr (1967) 0.92
[Structural characteristics of the antipsoriasic drugs chrysarobine and dithranol]. Hautarzt (1969) 0.91
[On the influence of 1,8-dihydroxy-9-anthrone (cignolin) on the transplantability and the metabolism of Ehrlich's ascitis tumor cells]. Klin Wochenschr (1967) 0.91
Fractionation of glycosaminoglycans from psoriatic skin. J Invest Dermatol (1970) 0.89
[Effect of cignolin on DNA synthesis in the epidermis]. Hautarzt (1969) 0.87
[ANALYSIS OF THE STRUCTURE OF ANTHRAROBIN AND ITS ACTION IN PSORIASIS]. Dermatologica (1965) 0.85
Studies on dithranol and dithranol-like compounds. II. Mutagenicity. Acta Derm Venereol (1971) 0.83
[Histochemical findings in psoriasis focal areas and their immediate vicinity during healing by Cignolin treatment]. Hautarzt (1966) 0.82
HISTOLOGICAL CHANGES IN PSORIASIS TREATED WITH DITHRANOL. Br J Dermatol (1964) 0.80
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med (1998) 7.48
Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med (1999) 3.37
Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol (1991) 2.07
The human peripheral lymphocyte--a model system for studying the combined effect of psoralen plus black light. Klin Wochenschr (1977) 1.97
The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol (1994) 1.94
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulagaris. I. The clinically normal appearing skin in the environment of blisters with a positive Nikolski phenomenon]. Arch Klin Exp Dermatol (1965) 1.94
Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol (1991) 1.93
Structural aspects of initial psoriatic lesions. Arch Dermatol Forsch (1974) 1.81
[Electron microscopic studies on the dynamics of acantholysis in pemphigus vulgaris. II. The acantholytic vesicle]. Arch Klin Exp Dermatol (1965) 1.75
Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood (2001) 1.74
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol (1991) 1.68
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg (2000) 1.65
[Dynamics of normal and pathological hair growth]. Arch Klin Exp Dermatol (1966) 1.62
[On the problem of optimal reacting conditions in the histochemical demonstration on enzymes of the energy-delivering metabolism in the epidermis. I. Dehydrogenase]. Arch Klin Exp Dermatol (1965) 1.60
Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol (2004) 1.55
[Microstructure of the epidermis in chronic nummular eczema. I. Stratum basale]. Arch Klin Exp Dermatol (1965) 1.54
Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5. Arch Dermatol (1997) 1.54
[Postoperative adjuvant therapy with interferon alfa-2B following laser surgery of condylomata acuminata]. Hautarzt (1990) 1.54
A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma. Clinical data and immunomonitoring. Cancer (1995) 1.52
Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer (1997) 1.50
Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol (2000) 1.49
[Stimulation of epidermal DNA syntgesis through vitamin A acid]. Arch Klin Exp Dermatol (1968) 1.48
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43
Late irradiation damage to the skin caused by soft X-ray radiation therapy of cutaneous tumors. Arch Dermatol (1995) 1.41
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
Spitz nevi display allelic deletions. Arch Dermatol (2001) 1.40
[Abnormal behavior of epidermal regeneration in patients with psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.39
Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol (1999) 1.39
Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol (1993) 1.39
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
Semiquantitative analysis of histologic criteria in thin malignant melanomas. J Am Acad Dermatol (1989) 1.38
Historic treasures in a new museum: dermatologic and surgical wax models. Int J Dermatol (1995) 1.38
[Epidermal regeneration of guinea pig's ear following the tearing off of the horny layer. A radioautographic study]. Arch Klin Exp Dermatol (1967) 1.38
Prognostic index in malignant melanoma. Arch Dermatol (1978) 1.36
Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer (1989) 1.35
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol (2001) 1.35
[Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol (1970) 1.33
[Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris]. Hautarzt (1976) 1.27
[Modification of epidermal differentiation by vitamin A acid. Electron microscopy study]. Arch Klin Exp Dermatol (1970) 1.25
Initial events in psoriasis: quantitative assessment. Br J Dermatol (1973) 1.24
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Mechanisms of parakeratosis. Br J Dermatol (1970) 1.22
Proliferative cells in the human sebaceous gland. Labelling index and regional variations. Acta Derm Venereol (1971) 1.21
Drug-induced lichen planus. Clin Dermatol (1998) 1.20
[Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol (1970) 1.19
Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol (1987) 1.17
[The morphogenesis of senile actinic elastosis. An electron microscopic study]. Arch Klin Exp Dermatol (1969) 1.16
[Normal pH value of human skin]. Hautarzt (1986) 1.16
[Electron microscopic studies of the dynamics of blister formation in bullous pemphigoid]. Arch Klin Exp Dermatol (1967) 1.15
[On the histotopy of enzymes of energy producing metabolism in the epidermis in psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.15
Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer (1995) 1.15
[Distribution of acid phosphatase in normal and psoriatic keratinization. (Electron microscopic and cytochemical studies)]. Dermatologica (1967) 1.14
[Trichostasis spinulosa]. Hautarzt (1967) 1.13
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood (1996) 1.13
Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer (1995) 1.12
[Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt (1983) 1.12
[Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test]. Hautarzt (1977) 1.12
[On histochemical enzyme demonstration in skin pathogenic fungi. II. Dermatophytes]. Arch Klin Exp Dermatol (1966) 1.11
[Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol (1970) 1.11
[Unusual adverse effects of oral photochemotherapy (PUVA-therapy) in psoriasis]. Hautarzt (1977) 1.11
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11
[On the enzymatic organization of the energy producing metabolism of normal guinea pig skin. 3. Activity determination of epidermal enzymes of the citric acid cycle and associated reactions]. Arch Klin Exp Dermatol (1966) 1.10
[On quantitative assessment of histochemical dehydrogenase demonstrations]. Histochemie (1965) 1.10
Occurrence of IgE-bearing epidermal Langerhans cells in atopic eczema: a study of the time course of the lesions and with regard to the IgE serum level. J Invest Dermatol (1989) 1.09
Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol (1996) 1.09
The dermal inflammatory reaction in initial psoriatic lesions. Arch Dermatol Res (1977) 1.09
[On the thickness of collagen fibrils in the embryonal skin]. Z Zellforsch Mikrosk Anat (1967) 1.09
Pseudo-melanoma after laser therapy. Dermatology (1998) 1.09
Reactivity of T cells in mycosis fungoides exhibiting marked epidermotropism with the monoclonal antibody HML-1 that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol (1989) 1.09
[On the histotopy of ubiquinone in human skin. I. Normal skin]. Arch Klin Exp Dermatol (1966) 1.08
Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol (1997) 1.08
Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood (1998) 1.07
Treatment of alopecia areata by anthralin-induced dermatitis. Arch Dermatol (1979) 1.07
Pseudopelade of Brocq. Dermatologica (1986) 1.06
Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem (1995) 1.05
Psoriatic hyperplasia: some measurements. Br J Dermatol (1970) 1.05
[Ultrastructure of dermal changes in human allergic skin test reaction]. Arch Dermatol Forsch (1971) 1.05
UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen. Br J Dermatol (1977) 1.04
Dermatofibroma: an abortive immunoreactive process mediated by dermal dendritic cells? Dermatology (1995) 1.04
[On the effect of the epilation technic on the normal and pathologic hair root pattern]. Arch Klin Exp Dermatol (1965) 1.04
Superficial acral fibromyxoma: report of two cases. Dermatology (2002) 1.03
Virus-like particles in the hamster melanoma A Mel 3 of fortner. Naturwissenschaften (1970) 1.03
Lectin typing of Haemophilus ducreyi. Eur J Clin Microbiol Infect Dis (1988) 1.02
[Ultrastructural changes of the epidermis in allergic patch test reaction]. Arch Dermatol Forsch (1970) 1.02
Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma. J Cancer Res Clin Oncol (1995) 1.02
[RNA-synthesis of the skin. DNA-dependent RNA-polymerase activity in guinea pig epidermis]. Arch Klin Exp Dermatol (1970) 1.01
[On the behavior of autoantibodies in bullous pemphigoid]. Hautarzt (1967) 1.01
Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. Am J Pathol (1989) 1.01
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol (1978) 1.01
Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol (1998) 1.00
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol (2001) 1.00
[On the problem of optimal reaction conditions in the histochemical demonstration of enzymes of energy-producing metabolism in the epidermis. II. Aldolase, tetrazolium reductase, cytochrome oxidase, ubiquinone]. Arch Klin Exp Dermatol (1966) 1.00
Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol (1990) 1.00
[Pagetoide reticulosis--Woringer-Kolopp's disease]. Hautarzt (1973) 0.99